Bromide

Bromide

SCHEMBL2068601

Br.O=C(O)Cc1cccc(Cc2ccc(P(c3ccccc3)c3ccccc3)cc2)c1

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.54
PLA2G10 O15496 3/20 0.54
AKR1B1 P15121 1/20 0.47
HNF4A P41235 1/20 0.43
LMNA P02545 3/20 0.42
GAA P10253 2/20 0.42
TSHR P16473 2/20 0.42
ABCC4 O15439 1/20 0.42
PTGS1 P23219 1/20 0.42
HTT P42858 1/20 0.42
KDM4E B2RXH2 3/20 0.41
HPGD P15428 3/20 0.41
HSD17B10 Q99714 3/20 0.41
ALDH1A1 P00352 2/20 0.41
MAPT P10636 2/20 0.41
IDH1 O75874 1/20 0.41
RGS12 O14924 1/20 0.41
POLB P06746 1/20 0.41
NFKB1 P19838 1/20 0.41
APEX1 P27695 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4557746 0.85 AKR1B1 (0.64) PLA2G2APLA2G10AKR1B1HNF4ALMNA
Acetic Acid SCHEMBL9783357 0.80 AKR1B1 (0.57) PLA2G2APLA2G10AKR1B1HNF4ALMNA
Hydrochloric Acid SCHEMBL2068170 0.80 IDH1 (0.44) PLA2G2APLA2G10HNF4ALMNATSHR
SCHEMBL10982048 0.76 CYP3A4 (0.52) PLA2G2APLA2G10HNF4AIDH1TDP1
SCHEMBL5696415 0.76 AKR1B1 (0.81) PLA2G2APLA2G10AKR1B1LMNAGAA
SCHEMBL70565 0.76 AKR1B1 (0.71) AKR1B1LMNAGAATSHRABCC4
Hydrochloric Acid SCHEMBL10986464 0.75 CYP3A4 (0.50) HNF4AKDM4EMAPTIDH1TDP1
Hydrochloric Acid SCHEMBL8922940 0.74 AKR1B1 (0.68) AKR1B1LMNAGAATSHRABCC4
Diphenylmethane SCHEMBL7563838 0.74 CYP3A4 (0.67) PLA2G2APLA2G10LMNAGAATSHR
SCHEMBL11143386 0.72 AKR1B1 (0.55) PLA2G2APLA2G10AKR1B1LMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9603833-B2 Benzene or thiophene derivative and use thereof as VAP-1 inhibitor R-TECH UENO, LTD. (JP) 2017-03-28 US disclosed
EP-2886534-A1 Benzene or thiophene derivative and use thereof as VAP-1 inhibitor R-Tech Ueno, Ltd. (JP) 2015-06-24 EP disclosed
US-20150166525-A1 BENZENE OR THIOPHENE DERIVATIVE AND USE THEREOF AS VAP-1 INHIBITOR R TECH UENO LTD (JP) 2015-06-18 US disclosed
US-8999989-B2 Benzene or thiophene derivative and use thereof as VAP-1 inhibitor R-TECH UENO, LTD. (JP) 2015-04-07 US disclosed
US-20110059957-A1 BENZENE OR THIOPHENE DERIVATIVE AND USE THEREOF AS VAP-1 INHIBITOR R-TECH UENO, LTD. (JP) 2011-03-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166525-A1 BENZENE OR THIOPHENE DERIVATIVE AND USE THEREOF AS VAP-1 INHIBITOR VAPB, VAPA, BET1 PLA2G2A 4599/4885PLA2G10 3993/4885AKR1B1 1808/4885
US-20110059957-A1 BENZENE OR THIOPHENE DERIVATIVE AND USE THEREOF AS VAP-1 INHIBITOR VAPB, VAPA, BET1 PLA2G2A 4599/4885PLA2G10 3993/4885AKR1B1 1808/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.